Abstract:Roberto W Dal Negro, 1 Paola Turco, 1 Massimiliano Povero 2 1 National Centre for Respiratory Pharmacoeconomics and Pharmacoepidemiology - CESFAR, Verona, Italy; 2 AdRes Health Economics and Outcomes Research, Turin, Italy Correspondence: Massimiliano Povero, Email Background: Chronic Obstructive Pulmonary Disease (COPD) is a respiratory condition characterized by heterogeneous abnormalities of the airways and lung parenchyma that cause different clinical presentations. The assessment of the prevailing pathogenetic components underlying COPD is not usually pursued in daily practice, also due to technological limitations and cost. Aim: To assess non-invasively the lung emphysema component of COPD by the simultaneous measurement of DL NO and DL CO via a single-breath (sDL NO and sDL CO ). Methods: COPD patients aged ≥ 40 years of both genders were recruited consecutively and labelled by computed tomography as "with significant" emphysema (> 10% of CT lung volume) or "with negligible" emphysema otherwise. Current lung function tests such as sDL NO , sDL CO and Vc (the lung capillary blood volume) were measured. All possible subsets of independent spirometric and diffusive parameters were tested as predictors of emphysema, and their predicted power compared to each parameter alone by ROC analysis and area under the curve (AUC). Results: Thirty-one patients with "significant emphysema" were compared to thirty-one with "negligible emphysema". FEV 1 and FEV1/FVC seemed to be the best spirometric predictors (AUC 0.80 and 0.81, respectively), while sDL CO and Vc had the highest predicted power among diffusive parameters (AUC 0.92 and 0.94, respectively). sDL CO and Vc values were the parameters most correlated to the extent of CT emphysema. Six subsets of independent predictors were identified and included at least one spirometric and one diffusive parameter. According to goodness-to-fit scores (AIC, BIC, log-likelihood and pseudo R 2 ), RV coupled with sDL CO or Vc proved the best predictors of emphysema. Conclusion: When investigating the parenchymal destructive component due to emphysema occurring in COPD, sDL NO , sDL CO and Vc do enhance the predictive power of current spirometric measures substantially. sDL NO , sDL CO and Vc contribute to phenotype of the main pathogenetic components of COPD easily and with high sensitivity. Organizational problems, radiation exposure, time and costs could be reduced, while personalized and precision medicine could be noticeably implemented. Keywords: COPD, parenchymal destruction, emphysema, lung capillary blood volume, simultaneous single-breath NO and CO diffusing capacity, precision medicine Chronic obstructive pulmonary disease (COPD) is a pathological condition of the lung that is characterized by persistent respiratory symptoms (cough, expectoration, dyspnea) due to heterogeneous disorders affecting the airways and/or the lung parenchyma to a variable extent. 1 Though characterized by significant progression and by huge epidemiological and socio-economic impact worldwide, 2–4 Nevertheless, COPD is described as a preventable and treatable condition. 1 It is known since long ago that the pathogenetic components underlying COPD can variably involve all structures of lung units, such as the conductive airways, the small airways and/or the alveoli, the capillary vasculature included. 5–7 Such a pathogenetic heterogeneity entails different clinical presentations of COPD: the clinical phenotypes of COPD. 8–19 Different COPD phenotypes can be obviously characterized by variable responses to therapeutic regimens due to the variable extent of reversible and irreversible components of structural disorders occurring in the lung, and consequently different short- and long-term outcomes can be expected. Unfortunately, respiratory conditions characterized by the predominant airway involvement and those where the parenchymal destruction is prevailing are currently included in the same comprehensive term "COPD", both in clinical practice and in the vast majority of RCTs. In the aim of defining the right pattern of lung function occurring in COPD and the existence of some destructive parenchymal components, measurements of diffusing capacity for carbon monoxide (DL CO ) are currently recommended together to the assessment of static and dynamic volumes, forced flows, airway resistances, and residual volume. However, due to the slow binding of CO with intracapillary hemoglobin (Hb), usual measurements of DL CO are consi -Abstract Truncated-

Decreased humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease

Bacterial load and related innate immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease

Systemic Alterations in Neutrophils and Their Precursors in Early-Stage Chronic Obstructive Pulmonary Disease

Risk factors of FEV1/FVC decline in COPD patients

Upregulation of Notch Signaling and Cell-Differentiation Inhibitory Transcription Factors in Stable Chronic Obstructive Pulmonary Disease Patients

Risk Factors for FEV1 Decline in Mild COPD and High-Risk Populations

Lung function decline in asthma patients with elevated bronchial CD8, CD4 and CD3 cells

Accelerated Lung Function Decline and Mucus-Microbe Evolution in Chronic Obstructive Pulmonary Disease

Imbalance of Peripheral Blood Th17 and Treg Responses in Patients with Chronic Obstructive Pulmonary Disease

Oxidative stress and Nrf2 expression in peripheral blood mononuclear cells derived from COPD patients: an observational longitudinal study

Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting

Reduced Tolerogenic Program Death-Ligand 1-Expressing Conventional Type 1 Dendritic Cells Are Associated with Rapid Decline in Chronic Obstructive Pulmonary Disease

Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease

Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study

Inflammatory Biomarkers in induced Sputum Predict Chronic Obstructive Pulmonary Disease (COPD) Severity

Phenotypic Profiling of Immune Cells and Their Mediators in Chronic Obstructive Pulmonary Disease

PHARMACOTHERAPY AND LUNG FUNCTION DECLINE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE : A SYSTEMATIC REVIEW

Impaired autophagy in the lower airways and lung parenchyma in stable COPD

Imbalance Between Subpopulations of Regulatory T Cells in Copd

Single-Breath Simultaneous Measurement of DLNO and DLCO as Predictor of the Emphysema Component in COPD – A Retrospective Observational Study

Age-associated phenotypic imbalance in TCD4 and TCD8 cell subsets: comparison between healthy aged, smokers, COPD patients and young adults